Studies indicated that the activation of PLCβ, PKCα or c‐Src has a critical role in tumour growth, cell migration, invasiveness and metastasis in breast cancer, colon carcinoma, lung squamous cell carcinoma and hepatocellular carcinoma cells.42, 43, 44, 45. The gene discussed is SRC; the disease is breast cancer.